Modular Peptide Coatings Regulate the Multistep Biological Performance of Lipid Nanoparticles for Enhanced mRNA Delivery
Summary
Lipid nanoparticles (LNPs) are a leading platform for mRNA delivery, yet improving their performance often requires complex chemical modification or reformulation of core components. Here, we report a modular peptide-coating strategy for post-formulation engineering of LNP interfaces through physical assembly. A modular multifunctional peptide (MFP) library was developed to systematically investigate how peptide composition, secondary structure, chirality, and concentration regulate coating assembly and delivery performance.
Keywords
Lipid nanoparticles (LNPs) are a leading platform for mRNA delivery, yet improving their performance often requires complex chemical modification or reformulation of core components. Here, we report a modular peptide-coating strategy for post-formulation engineering of LNP interfaces through physical assembly. A modular multifunctional peptide (MFP) library was developed to systematically investigate how peptide composition, secondary structure, chirality, and concentration regulate coating assembly and delivery performance. In vitro, MFP coatings enhanced cellular uptake, endosomal escape, and mRNA translation. In vivo, optimized coatings improved mRNA delivery across multiple LNP formulations and promoted receptor-mediated tumor-specific accumulation and expression. In an IL-12 mRNA immunotherapy model, MFP-coated LNPs elicited potent antitumor immune responses and inhibited tumor growth without observable systemic toxicity. This work establishes a modular peptide surface engineering strategy for regulating LNP biological performance and provides an expandable framework for developing a tissue- and disease-specific nanomedicine platform through the tailoring of peptide functional modules.
Abstract from PubMed (PMID 43002012). This entry was added automatically by our daily literature monitor because it matches the topics we follow; read the full paper at the original source.
Related articles
Theranostic lipid nanocarriers for precision diagnosis and targeted therapy in pancreatic ductal adenocarcinoma
Journal of chemical information and modelingInsights into Composition-Induced Structural Shifts in Lipid Nanoparticles
Nanomedicine (London, England)Nanotechnology-enabled drug delivery for retinoblastoma: formulation strategies, ocular targeting and translational perspectives
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
